dihydroxyphenylalanine has been researched along with Leukemia, Myeloid in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spiers, AS | 1 |
1 other study available for dihydroxyphenylalanine and Leukemia, Myeloid
| Article | Year |
|---|---|
Ineffectiveness of dextrodopa in chronic granulocytic leukaemia.
Topics: Adult; Chronic Disease; Dihydroxyphenylalanine; Female; Hemoglobins; Humans; Leukemia, Myeloid; Leuk | 1974 |